Global Amniotic Products Market to Surpass $1.54 Billion by 2027 – ResearchAndMarkets.com

Global Amniotic Products Market to Surpass $1.54 Billion by 2027 – ResearchAndMarkets.com




Global Amniotic Products Market to Surpass $1.54 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Amniotic Products Market Research Report by Type, Application, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Amniotic Products Market size was estimated at USD 892.36 million in 2021, USD 976.06 million in 2022, and is projected to grow at a CAGR 9.63% to reach USD 1,549.65 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Amniotic Products to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Amniotic Membranes and Amniotic Suspensions. The Amniotic Membranes is further studied across Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes.
  • Based on Application, the market was studied across Ophthalmology, Orthopedics, and Wound Care.
  • Based on End-User, the market was studied across ASCs and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Amniotic Products Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Market Dynamics

Drivers

  • Potential demand attributed to the chronic pains coupled with burn injuries
  • Rising awareness campaigns for wound care treatment with care
  • Increasing surgeries associated with ophthalmology along with cosmetics worldwide

Restraints

  • Concern regarding the frauds in providing amniotic products

Opportunities

  • Growing research and development for novel amniotic products
  • Upsurging governmental and private fundings
  • Ongoing trend for transplantation of amniotic membranes

Challenges

Limited availability of amniotic fluids

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Amniotic Products Market, by Type

7. Amniotic Products Market, by Application

8. Amniotic Products Market, by End-User

9. Americas Amniotic Products Market

10. Asia-Pacific Amniotic Products Market

11. Europe, Middle East & Africa Amniotic Products Market

12. Competitive Landscape

13. Company Usability Profiles

14. Appendix

Companies Mentioned

  • Applied Biologics LLC
  • Celularity Inc.
  • Genesis Biologics Inc.
  • Integra LifeSciences Holdings Corporation
  • Katena Products, Inc.
  • LifeCell International Pvt. Ltd.
  • Lucina BioSciences
  • Merakris Therapeutics Inc.
  • MiMedx Group
  • Next Biosciences Pty Ltd.
  • NuVision Biotherapies Ltd.
  • Organogenesis Holdings Inc.
  • Orthofix Medical Inc.
  • Skye Biologics Holdings LLC
  • Smith & Nephew plc
  • Stryker Corporation
  • Surgenex LLC
  • TissueTech, Inc.
  • Ventris Medical LLC
  • VIVEX Biologics Inc. 

For more information about this report visit https://www.researchandmarkets.com/r/dpfvw5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900